Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Everplay announces new 'Hell Let Loose' instalment

(Sharecast News) - Everplay Group announced Hell Let Loose: Vietnam on Thursday, a new instalment in its successful first-person multiplayer shooter franchise, scheduled for release in 2026 on Xbox, PlayStation, Epic Games Store and Steam. The AIM-traded company said the original Hell Let Loose, set during World War II and acquired by Everplay in 2022, had generated over $100m in lifetime revenue with record player engagement reported in 2024 and concurrent users peaking above 144,000 in 2025.

It said the Vietnam edition would retain the core gameplay while introducing historically based combat from the 1965-1973 conflict, featuring combined arms warfare across six new maps.

New elements included fully operational helicopters for troop deployment, US patrol boats, and guerrilla warfare set in dense terrain, developed in partnership with Expression Games using Unreal Engine 5.

"Today's announcement reflects our ongoing commitment to expanding our portfolio through new content and sequels built around our most successful and enduring franchises," said interim executive chair Frank Sagnier.

"Hell Let Loose is one of our most iconic own-IP titles with a loyal global fanbase, and Hell Let Loose: Vietnam represents a bold step forward for the franchise, delivering an all-new experience for fans."

Everplay said players of the original game would continue to receive new content and support through 2026 and beyond as part of its strategy to grow first-party IP and evergreen franchises.

At 1526 BST, shares in Everplay Group were down 0.8% at 373p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.